Digoxigenin
SIAL/D9026 - analytical standard
Synonym: 3β,12β,14β,21-Tetrahydroxy-20(22)-norcholenic acid lactone; 3β,12β,14-Trihydroxy-5β,20(22)-cardenolide; 5β,20(22)-Cardenolide-3β,12β,14-triol; Lanadigigenin
CAS Number: 1672-46-4
Empirical Formula (Hill Notation): C23H34O5
Molecular Weight: 390.51
EC Number: 216-806-2
MDL Number: MFCD00871861
Linear Formula: C23H34O5
Product Type: Chemical
agency | EPA 1694 |
application(s) | environmental food and beverages forensics and toxicology veterinary |
assay | ≥98% (HPLC) |
format | neat |
functional group | ketone |
grade | analytical standard |
InChI | 1S/C23H34O5/c1-21-7-5-15( |
InChI key | SHIBSTMRCDJXLN-KCZCNTNESA |
mp | 222 °C (lit.) |
Quality Level | 100 |
SMILES string | C[C@]12CC[C@H](O)C[C@H]1C |
storage temp. | room temp |
technique(s) | gas chromatography (GC): suitable |
HPLC: suitable |
Application: | Digoxigenin is used as an analytical reference standard for the quantification of the analyte in biological samples using high-performance liquid chromatography couped to tandem mass spectrometry. |
Application: | Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support. |
General description: | Digoxigenin is a therapeutic drug belonging to the group of cardiac glycosides, widely used in the management of congestive heart failure and other cardiac diseases. |
Packaging: | 25, 100, 500 mg in glass bottle |
Symbol | GHS06 |
Signal word | Danger |
Hazard statements | H300 + H310 + H330 |
Precautionary statements | P262 - P280 - P301 + P310 + P330 - P302 + P352 + P310 - P304 + P340 + P310 |
Hazard Codes | T+ |
Risk Statements | 26/27/28 |
Safety Statements | 36/37/39-45 |
RIDADR | UN 2811PIH 6.1 / PGI |
WGK Germany | WGK 3 |
Purity | ≥98% (HPLC) |
mp | 222 °C (lit.) |
Storage Temp. | room temp |
UNSPSC | 41116107 |